跳至主要内容
临床试验/NCT02695758
NCT02695758已完成不适用

Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing Shoulder Arthroplasty (TSA): A Randomized Trial

Rothman Institute Orthopaedics0 个研究点目标入组 156 人开始时间: 2014年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
156
主要终点
Morphine and Morphine Equivalent consumption

研究概览

简要总结

A non-blinded randomized controlled trial, in which participants undergoing primary reverse or total shoulder arthroplasty are randomly assigned to one of two treatment groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •1. All individuals undergoing primary reverse and total shoulder arthroplasty by the shoulder service at Methodist Hospital or Rothman Specialty Hospital.

排除标准

  • •Psychiatric illness as defined by co-morbid diagnosis of bipolar disorder or schizophrenia
  • •Revision arthroplasty, arthroplasty for fracture
  • •Unable/unwilling to consent for enrollment
  • •Unable to complete postoperative pain survey
  • •Known adverse drug reaction or allergy to the medications used
  • •Chronic pain syndromes (including reflex sympathetic dystrophy, fibromyalgia, chronic diffuse musculoskeletal pain)
  • •Patients taking long acting narcotic pain medications (including extended release narcotic pain medications and methadone).
  • •Patients under the age of 18 years
  • •Patients with history of hepatic disease
  • •Pregnant women or women who are breastfeeding

研究组 & 干预措施

interscalene brachial plexus block

Active Comparator

Direct interscalene nerve block injection via brachial plexus

干预措施: Interscalene brachial plexus block (Procedure)

Bupivacaine extended-release liposome injection

Active Comparator

Infiltration of local anesthetic/analgesic, Bupivacaine extended-release liposome injection (Exparel) + Diluted in 40cc of Saline into the capsule, subscapularis, deltoid, pectoralis major and subcutaneous tissues.

干预措施: bupivacaine extended-release liposome injection (Procedure)

结局指标

主要结局

Morphine and Morphine Equivalent consumption

时间窗: 24 hours following surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验